Esthesioneuroblastoma CT: Difference between revisions
No edit summary |
Simrat Sarai (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Esthesioneuroblastoma}} | {{Esthesioneuroblastoma}} | ||
{{CMG}}{{AE}}{{Simrat}} | |||
==Overview== | |||
==CT== | |||
CT is particularly useful in assessing bony destruction, although it cannot distinguish olfactory neuroblastomas from other tumors that arise in the same region. The mass is of soft tissue attenuation, with relatively homogeneous enhancement 3. Focal calcification are occasionally present 3. | |||
These tumors are relatively slow growing and thus, the bony margins are often remodeled and resorbed, rather than being aggressively destroyed | |||
==References== | ==References== | ||
Revision as of 15:49, 13 January 2016
|
Esthesioneuroblastoma Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Esthesioneuroblastoma CT On the Web | |
|
American Roentgen Ray Society Images of Esthesioneuroblastoma CT | |
|
Risk calculators and risk factors for Esthesioneuroblastoma CT | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
CT
CT is particularly useful in assessing bony destruction, although it cannot distinguish olfactory neuroblastomas from other tumors that arise in the same region. The mass is of soft tissue attenuation, with relatively homogeneous enhancement 3. Focal calcification are occasionally present 3. These tumors are relatively slow growing and thus, the bony margins are often remodeled and resorbed, rather than being aggressively destroyed